PerkinElmer (NYSE:PKI) is expected to report Q4 earnings on Thursday, January 29 after the market close, with a conference call scheduled for 5:00 pm ET.
Analysts are expecting a profit of 42c on revenue of $516M. The consensus range for EPS is 41c-45c with a revenue range of $497M-$534M, according to First Call. For Q3, the company reported EPS 37c vs. consensus of 36c and revenue $505.1M vs. consensus of $503.11M. Positive contributors for this quarter could come from strength in the Life and Analytical Sciences segment and from from acquisitions.The main negative potential for Q4 is a spending cut-back from hospitals.
In a recent research note, Leerink Swann commented on the Life Sciences Equipment makers: "Following comments from individual management teams at recent investor conferences, we expect the default position to be the issuance of muted 2009 guidance, as companies take a cautious look at the current economy, health care spending trends, and capital spending in both lab and hospital environments."